Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression

BACKGROUND: Despite the importance of androgen receptor (AR) signalling to prostate cancer development, little is known about how this signalling pathway changes with increasing grade and stage of the disease. OBJECTIVE: To explore changes in the normal AR transcriptome in localised prostate cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuchbery, Ryan, Macintyre, Geoff, Cmero, Marek, Harewood, Laurence M., Peters, Justin S., Costello, Anthony J., Hovens, Christopher M., Corcoran, Niall M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058764/
https://www.ncbi.nlm.nih.gov/pubmed/27120785
http://dx.doi.org/10.18632/oncotarget.8915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058764/
https://www.ncbi.nlm.nih.gov/pubmed/27120785
http://dx.doi.org/10.18632/oncotarget.8915

Ejemplares similares